In our review, we summarize evidence from randomized clinical trials and meta-analyses showing that ten approved and emerging obesity medications can improve a remarkably broad range of obesity-related conditions, including: Liver disease (MASLD and MASH) Chronic kidney disease PCOS (now increasingly referred to as PMOS, polyendocrine metabolic-ovarian syndrome) Obstructive sleep apnoea Osteoarthritis and physical functioning Cardiovascular disease Prediabetes and type 2 diabetes Importantly, many of these benefits are related to weight loss itself
We consistently follow the Clean Label philosophy our products contain no added sugar, artificial sweeteners or synthetic preservatives
However, starting in July 2026, a new program called the BALANCE Model may give eligible Medicare Part D beneficiaries access to certain GLP-1 weight loss medications for a $50 copay
Crafted with purity and your well-being in mind, these capsules boast a powerful antioxidant formula designed to support your body's natural defense systems, without the use of unnecessary additives
Consider this your gentle toolkit for evening meals that support healing, peace, and better sleep